Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-22

Clinical Trial Update: Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on oral 6-bromotryptophan assessing safety, pharmacokinetics, and efficacy in metabolic syndrome and diabetes mellitus across Phase 1 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 6-bromotryptophan (6-bromotryptophan)

Snippet

Sponsor: Nordin Hanssen | Conditions: Metabolic Syndrome, Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN